Year None20232022202120202019 Feb 03, 2023 Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Jan 14, 2023 Arcutis Presents New Phase 2 Long-Term Data Showing Sustained Efficacy and Clearance for a Median of Jan 05, 2023 Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) First page « first Previous page ‹ previous Page 1 Page 2 Current page 3 Displaying 19 - 21 of 21